Results 21 to 30 of about 396,796 (347)

In Vivo and in Vitro Investigations of the Effects of Iranian Honeybee (Hymenoptera: Apis mellifera) Venom and Propolis on Leishmania Major [PDF]

open access: yesJournal of Health Sciences and Surveillance System, 2023
Background: Leishmaniasis, as a neglected health issue, is spreading in most parts of the world. It is one of the most important vector-borne diseases in Iran. Bee venom has shown a wide range of medicinal properties.
Qasem Asgari   +5 more
doaj   +1 more source

Effects of a new anti-ulcer agent (HAU-102) on experimental gastric ulcers

open access: goldJapanese Journal of Pharmacology, 1988
Masaru Saita   +4 more
openalex   +3 more sources

Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant users [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2023
Background/Aims Capsule endoscopy (CE) has shown that low-dose aspirin occasionally causes small bowel (SB) bleeding. We herein evaluated the protective effects of mucoprotective agents (MPAs) on SB bleeding in aspirin users using the nationwide database
Hyun Seok Lee   +4 more
doaj   +1 more source

Composition and Anti-ulcer Activity of the Essential Oil from Citri Reticulatae Pericarpium in Rodents [PDF]

open access: yesBrazilian Archives of Biology and Technology, 2023
The essential oil from Citri Reticulatae Pericarpium (EOC) was analyzed by GC/MS. The major component of EOC was found to be d-limonene (92.3% of the total essential oil).
Qingyao Li   +3 more
doaj   +1 more source

Systematic Analysis of Monoterpenes: Advances and Challenges in the Treatment of Peptic Ulcer Diseases

open access: yesBiomolecules, 2020
Peptic ulcer disease (PUD) is a multifactorial and complex disease caused by an imbalance of protective and aggressive factors (endogenous and exogenous).
Larissa Lucena Périco   +8 more
doaj   +1 more source

Refractory Peptic Ulcer Disease [PDF]

open access: yesThe Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2019
The eradication of Helicobacter pylori and the widespread use of effective antisecretory therapies, including proton pump inhibitors, have improved the management of peptic ulcer disease. However, in some patients, peptic ulcer disease is refractory to 8
Hyun Lim
doaj   +1 more source

GASTRIC ULCER AFTER SHORT-TERM NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ADMINISTRATION IN A SMALL CHILD – CASE REPORT [PDF]

open access: yesRomanian Journal of Pediatrics, 2015
Nonsteroidal anti-inflammatory agents (NSAIDs) produce gastric lesions through two mechanisms: local irritation and systemic action. A 2 year and 10 months old female received NSAID for acute upper respiratory infection for 2 days and she developed ...
Ancuta Ignat   +5 more
doaj   +1 more source

Exendin-4, a glucagon-like peptide-1 analogue accelerates healing of chronic gastric ulcer in diabetic rats. [PDF]

open access: yesPLoS ONE, 2017
Diabetes mellitus is an independent risk factor for impaired healing of peptic ulcers, and there are currently no supplementary therapeutics other than the standard antipeptic medicine to improve the ulcer healing in diabetes.
Yen-Cheng Chen   +5 more
doaj   +1 more source

Effects of KP-105, a novel anti-ulcer agents, on various ulcer models

open access: goldJapanese Journal of Pharmacology, 1997
Masahiro Fujil   +5 more
openalex   +3 more sources

Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study [PDF]

open access: yes, 2006
OBJECTIVE: In recent years, studies investigated to what extend recommendations for co-prescribing gastroprotective agents in prevention of NSAID-induced gastrointestinal complications are followed in clinical practice.
Bilušić, Marinko   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy